We are live on
!
Find out more
AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
48 hedge funds and large institutions have $73.6M invested in Agile Therapeutics in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
86% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23% less funds holding
Funds holding: 62 → 48 (-14)
45% less capital invested
Capital invested by funds: $133M → $73.6M (-$59.8M)
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Holders
48
Holders Change
-14
Holders Change %
-22.58%
% of All Funds
1.19%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
9
Increased
13
Reduced
7
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$1.72M |
| 2 |
RA
Royce & Associates
New York
|
+$1.67M |
| 3 |
BlackRock
New York
|
+$1.6M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$1.59M |
| 5 |
DM
Deerfield Management
New York
|
+$1.44M |
